The World Health Organization (WHO) has evaluated the effectiveness of four drugs against coronavirus infection. As it turns out, remdesivir, hydroxychloroquine, lopinavir / ritonavir and interferon have little effect on reducing mortality in the treatment of COVID-19 in a hospital setting.
This conclusion was made on the basis of the interim results of the clinical study Solidarity (translated from English - solidarity), coordinated by the WHO, writes TASS. It covers 30 countries: experts are studying the effect of treatment with these drugs on mortality rates and the length of stay of patients in hospitals, Uralinformburo reports.
"The use of remdesivir, hydroxychloroquine, lopinavir / ritonavir and interferon appears to have little or no effect on mortality [reduction] after 28 days or hospital treatment for COVID-19 among hospitalized patients," the WHO said in a statement.
It is worth recalling that at the very beginning of the pandemic, some experts argued that one or another drug from this list was very promising. In particular, the Americans actively promoted remdesivir. Russia is among the countries that have approved it for the treatment of those infected.
At the same time, lopinavir / ritonavir was recently deleted from domestic recommendations for the treatment of COVID-19.